HIGHLIGHTS
- who: Andreas O. Kruse from the (UNIVERSITY) have published the research: Glutamatergic dysfunction in Schizophrenia, in the Journal: (JOURNAL) of 10/05/2022
- what: When meta-analyses were not available, the authors identified the most recent narrative reviews; when these were not available, the authors focused on the largest studies. One hundred and thirty four studies, involving 7993 subjects with schizophrenia-spectrum disorders and 8744 HV were included and effect sizes (g) were examined in 14 regions of interest (ROIs). This study had several strengths like having the largest longitudinal sample to date and having . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.